Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Confirms Crawford As FDA Commissioner In 78-16 Vote

This article was originally published in The Gray Sheet

Executive Summary

Lester Crawford's nomination to be FDA's permanent commissioner cleared the Senate July 18 by a vote of 78-16

You may also be interested in...



Von Eschenbach Nomination To Head FDA Already Mired In “Plan B” Politics

No sooner did President Bush nominate Acting FDA Commissioner Andrew von Eschenbach March 15 to permanently head the agency than Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) announced they would place a hold on the nomination

Von Eschenbach Nomination To Head FDA Already Mired In “Plan B” Politics

No sooner did President Bush nominate Acting FDA Commissioner Andrew von Eschenbach March 15 to permanently head the agency than Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) announced they would place a hold on the nomination

FDA Personnel Moves Suggest Continuity Is Focus of Commissioner Crawford

Five top-level FDA personnel changes codify much of the structure that was created after Commissioner Lester Crawford became acting head of the agency in February 2004

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022439

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel